Nipun B. Merchant
- Oncology top 0.2%
- Pancreatic and Hepatic Oncology Research 121
- Cancer Immunotherapy and Biomarkers 12
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 32
-
- Gastric Cancer Management and Outcomes 18
- Renal cell carcinoma treatment 12
- Surgery top 1%
- Pancreatitis Pathology and Treatment 29
- Rheumatology top 1%
-
- Neuroendocrine Tumor Research Advances 26
-
- Gastrointestinal Tumor Research and Treatment 13
- Co-authors
- Murray F. BrennanM. Kay WashingtonDenis H. Y. LeungNagaraj S. NagathihalliRobert J. CoffeyJason CastellanosAlexander A. ParikhShawn Levy
- Partner nations
- United StatesCanadaGermany
In The Last Decade
Nipun B. Merchant
202 papers receiving 7.6k citations
Hit Papers
Peers
Comparison fields: 5 of 147
- Oncology 5.0k
- Cancer Research 1.1k
- Pulmonary and Respiratory Medicine 2.0k
- Surgery 2.1k
- Rheumatology 652
Countries citing papers authored by Nipun B. Merchant
This map shows the geographic impact of Nipun B. Merchant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nipun B. Merchant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nipun B. Merchant more than expected).
Fields of papers citing papers by Nipun B. Merchant
This network shows the impact of papers produced by Nipun B. Merchant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nipun B. Merchant. The network helps show where Nipun B. Merchant may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nipun B. Merchant, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 15 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 18 | |
| 5 | 2023 | 20 | |
| 6 | 2022 | 4 | |
| 7 | 2021 | 25 | |
| 8 | 2021 | 33 | |
| 9 | 2021 | 7 | |
| 10 | 2020 | 40 | |
| 11 | 2020 | 10 | |
| 12 | 2019 | 87 | |
| 13 | 2018 | 97 | |
| 14 | 2018 | 32 | |
| 15 | 2018 | 17 | |
| 16 | 2018 | 39 | |
| 17 | 2014 | 96 | |
| 18 | 2011 | 83 | |
| 19 | 2010 | 83 | |
| 20 | 2008 | 82 |
About Nipun B. Merchant
Nipun B. Merchant is a scholar working on Oncology, Cancer Research and Gastroenterology, having authored 212 papers that have together received 7.7k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (121 papers), Cancer Genomics and Diagnostics (32 papers), Pancreatitis Pathology and Treatment (29 papers), Neuroendocrine Tumor Research Advances (26 papers), Gastric Cancer Management and Outcomes (18 papers), Gastrointestinal Tumor Research and Treatment (13 papers), Renal cell carcinoma treatment (12 papers) and Cancer Immunotherapy and Biomarkers (12 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (1.1k citations) and Pulmonary and Respiratory Medicine (2.0k citations). Nipun B. Merchant has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include Murray F. Brennan, M. Kay Washington, Denis H. Y. Leung, Nagaraj S. Nagathihalli, Robert J. Coffey, Jason Castellanos, Alexander A. Parikh, Shawn Levy, James M. Woodruff and Richard M. Caprioli. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.